Treating diabetic nephropathy: unfinished success is not failure.
Lewis
Julia
J
D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003922:Diabetes Mellitus, Type 1; D003924:Diabetes Mellitus, Type 2; D003928:Diabetic Nephropathies / Q000188:drug therapy* / Q000503:physiopathology; D004059:Diffusion of Innovation; D018450:Disease Progression; D019983:Guideline Adherence; D006801:Humans; D012084:Renin-Angiotensin System / Q000187:drug effects
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors